Case File
efta-efta00668285DOJ Data Set 9OtherFrom: Steven Victor MD ‹
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00668285
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Steven Victor MD ‹
>
To:
Subject: Great news re Patent
Date: Fri, 18 Jan 2013 16:17:05 +0000
Dear Shareholder, Investor and Friend,
We have received a notice of allowance from the US Patent Office for our U.S. Patent Application No.
13/323,030 for the Invention "Ultrasonic Cavitation Derived Stromal Vascular Fraction and Cells
Derived therefrom obtained from Adipose Tissue and Use Thereof.
The patent application contains claims drawn to a method of using ultrasonic cavitation to isolate
stromal vascular fraction cells from adipose tissue without requiring the use of enzymes.
This mean the patent is allowed and will be for final publication in approx 30 days after we pay the
application fee.
I believe this is a major step forward for the company and I thank the entire staff for their hard work.
We look forward to an exciting and fruitful 2013.
Steven Victor MD
IntelliCell BioSciences
Chairman/CEO
460 Park Avenue 17th Floor
New York, New York 10022
212-249-3050
Fax 212-249-1482
Cell 917-459-8252
www.IntelliCellBioSciences.com
EFTA00668285
Technical Artifacts (5)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
www.intellicellbiosciences.comFax
Fax 212-249-1482Phone
212-249-1482Phone
212-249-3050Phone
917-459-8252Related Documents (6)
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.